ACME-PORTABLE
13.5.2014 12:10:39 CEST | Business Wire | Pressemeddelelse
ACME Portable, the manufacturer of high-performance portable computers, is showcasing at CEIC 2014, BoothNo. 413 the new Portable Forensic Workstation.
Digital Forensics
In this digital age, we are seeing an increase in hack attacks, data theft, money laundering, and more. Computer forensics is the investigation of suspicious systems. Before the examination and analysis can be performed, the data of these suspicious systems must be saved as evidence. In other words, duplicates must be created. The data cannot be manipulated in any way, and as a result, write-blockers are used to ensure that the data is secured ant not altered. The challenge is doing this task in a quick and easy method.
Sherlock Lite Workstation
The Sherlock Lite is the perfect portable solution that is excellent at doing this task. Forget about bulky equipment and heavy computers. Cloning large amounts of data from existing HDDs is no longer a difficult task.
The unit is a very compact and portable computer. Despite its compact design, it can be integrated with the latest Intel multi-core processors, a lot of memory, multiple hard drives, and all possible connectors.
Notebook computers are not an adequate solution because they lack the necessary connectors, speed, and performance. However, our portable computer is an all-in-one, lightweight, durable, compact, cool and quiet solution for easy data replication.
While other units may have an external write-blocker, our unit comes with the write-blocker already installed. At an affordable price, this unit can deliver high performance, replicate data at high speeds, and be deployed at any location.
Simply put, the Sherlock Lite makes data acquisition affordable, less time-consuming, and less tedious. Investigators can capture criminals in the shortest possible time.
Features:
- Accurate duplicates (hash function)
- 3 removable 3.5"SATA drives
- Integrated Write blocker
- 32 GB DDR3 (upgradable)
- 18TB of data storage
- Molex connector
- Extensive Connectors: 4xUSB 3.0, 4xUSB 2.0, 2xeSATA, 1xLAN, 1xFW400, 2xFW800
- Optional: SCSI,IDE and SAS connectors
- Water Cooling
About ACME Portable
Founded in 1994, ACME Portable is headquartered in USA, with branch offices in Europe and Taiwan. We are dedicated to manufacturing the most integrated portable computers in the marketplace. All ACME portables are designed and manufactured right down to detailed specifications.
Visit www.acmeportable.de for more information.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140513005834/en/
Contact:
ACME Portable
Timos Tamvakis
Tel: +4972157045313
timos@acmeportable.de
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
New Iconic Landmark Danjiang Bridge Opened to Redefine Taiwan18.5.2026 12:02:00 CEST | Press release
The Danjiang Bridge, one of Taiwan’s most significant recent public infrastructure projects, officially opened with a series of large-scale public events, transforming the bridge into a new cultural landmark and civic space. The program featured the “Danjiang Bridge Together Arts Festival,” immersive public activities, and a special performance of Light Chain by Cloud Gate Dance Theatre, symbolizing the integration of architecture, engineering, and the arts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260517667930/en/ The Danjiang Bridge is an iconic landmark in Taiwan with global recognition. (Photo via Highway Bureau , Motc) Spanning the mouth of the Tamsui River, the bridge serves as both a major transportation project and a recognizable architectural landmark, establishing a new urban symbol for Taiwan. Designed by Zaha Hadid Architects, the project gained international attention throughout its development and was sel
Arboris Capital Selects ROYC to Expand Private Markets Capabilities on CapGain Platform18.5.2026 09:00:00 CEST | Press release
Arboris Capital Limited (“Arboris”), a DIFC-based firm arranging alternative investments, authorised by the Dubai Financial Services Authority (DFSA), today announced that it has selected ROYC AB (“ROYC”), a private markets technology and infrastructure provider, to support the continued development of its private markets offering through its platform, CapGain. In its ongoing efforts to expand its private markets capabilities across the Middle East, Arboris has undertaken a strategic review of how to further scale its offering while maintaining the integrity of its existing platform. As a result, Arboris has chosen to integrate ROYC’s fund access, sourcing, and structuring capabilities into CapGain, complementing its existing infrastructure. CapGain is Arboris’s proprietary investment platform, purpose-built to facilitate access between international private market opportunities and Professional Investors in the region. CapGain provides fully digital investor onboarding and KYC, a secu
OdysseyRe Announces New Co-Chief Underwriting Officers for EMEA18.5.2026 09:00:00 CEST | Press release
Odyssey Reinsurance Company (OdysseyRe) today announced the appointments of Tegwen Gromellon and Anne-Claire Serres as co-chief underwriting officers of its EMEA division, effective July 1. They succeed longtime Chief Underwriting Officer, Gaël Le Païh, who is retiring later this year following 36 years with the Company. Based in Paris, Serres joined OdysseyRe in 2018 as the market director for France and will lead the division’s business across France, Africa and the Middle East. Gromellon, who joined OdysseyRe in 2004, has served as market director for Germany, Austria, Benelux and Switzerland since 2019. He will take the lead for the rest of Europe, including the relationship with the Company’s representative office in Stockholm for the Nordic markets and across Turkey. “We are delighted to appoint both Tegwen and Anne-Claire to these important leadership positions,” said Isabelle Dubots-Lafitte, chief executive officer of EMEA for OdysseyRe. “These appointments recognize their sign
LogicMonitor and Deutsche Telekom Expand Partnership Across Europe18.5.2026 09:00:00 CEST | Press release
Expanded availability of LogicMonitor within Deutsche Telekom’s managed services portfolio follows successful operational use in the UKSelect outcomes include reduced reporting times and proactive incident preventionExpansion extends across DACH, Benelux, and the Nordics LogicMonitor®, the AI-first platform for Autonomous IT, today announced the expanded availability of its platform within Deutsche Telekom’s managed services portfolio across selected European markets, including DACH, Benelux, and the Nordics. The expansion builds on operational use of LogicMonitor in the United Kingdom since 2023, where it has supported Deutsche Telekom’s service teams in improving visibility across network, cloud, and hybrid infrastructure environments. Experience gained from these deployments is now informing broader service enablement across additional European markets. As enterprise IT environments grow more complex, organisations require more than visibility—they need predictive resilience. Throug
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy18.5.2026 09:00:00 CEST | Press release
ZH9 is very well tolerated with a favourable safety profile, and no dose-limiting toxicities or Grade ≥3 drug-related adverse events reported.ZH9 demonstrates 91% freedom-from-relapse in NMIBC patients who have reached study end.Company plans to run a larger phase 2 study across a range of patient populations spanning intermediate risk and high risk including CIS. Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumours, today announced safety and antitumour efficacy results from an interim review of the ongoing Phase 1/1b PARADIGM-1 trial of ZH9 in non-muscle invasive bladder cancer (NMIBC) patients. These data were shared via an oral podium presentation at the American Urology Association (AUA26) Annual Meeting. Prokarium CMO, Dr Josefin-Beate Holz said “These data demonstrate ZH9 as a universally applicable treatment for patients. As the treatment is very well tolerated and is showing impactful outcomes for early a
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum